Press Releases

Press Releases

  1. Recommended Cash Offer for BTG plc by Boston Scientific Corporation

  2. BTG plc: Interim Results 2018

  3. BTG Sentry Bioconvertible IVC Filter 2-year Study Results Show Zero Tilt, Migration, Perforation, Fracture, or Embolization

  4. EKOS™ Control Unit 4.0 simplifies treatment of blood clots

  5. BTG plc: Directorate change

  6. BTG plc: close period update

  7. BTG Announces Replacement Policy for Expired CroFab®

  8. BTG announces global launch of the ICEfx™ Cryoablation System

  9. FDA Approves CroFab® Product Improvements

  10. BTG plc acquires Novate Medical Ltd.

  11. BTG receives not-approvable letter from the US FDA for ELEVAIR™

  12. OPTALYSE PE Results Published in JACC: Cardiovascular Interventions

  13. BTG plc: Annual General Meeting

  14. PERT Consortium and BTG Form Strategic Partnership

  15. Historical Financial Information Restated to US Dollars

  16. Result of FDA Advisory Committee vote on Elevair™ for the treatment of severe emphysema

  17. ELEVATE study aims to improve selection criteria and outcomes for patients with severe emphysema treated with the PneumRx™ Endobronchial Coil System

  18. BTG plc: Final Results 2018

  19. OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions

  20. BTG plc: close period update

  21. SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

  22. OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  23. Appointment of Non-executive Director